ABBV AbbVie Inc.
263.08USD-1.06%Mkt Cap: 469.63B $P/E: 75.07Today
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimm…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap469.63B USD
Enterprise Value528.80B USD
Revenue (TTM)64.39B USD
Gross Profit42.96B USD
Net Income (TTM)4.23B USD
Revenue/Share36.39 USD
Last Price263.08 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees57.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)75.07
P/E (Forward)16.16
PEG0.54
EV/EBITDA17.19
EV/Revenue8.21
P/S7.21
P/B-78.24
EPS (TTM)3.54
EPS (Forward)16.26
52W Range
190.7592% of range269.39
52W High269.39 USD
52W Low190.75 USD
Profitability
Gross Margin70.24%
Oper. Margin40.03%
EBITDA Margin47.78%
Profit Margin6.91%
ROE-129.24%
ROA3.15%
Growth
Revenue Growth10.20%
Earnings Growth290.40%
Cash Flow & Leverage
Operating CF19.03B USD
CapEx (TTM)1.21B USD
FCF Margin26.20%
FCF Yield3.59%
Net Debt64.32B USD
Net Debt/EBITDA2.09
Balance Sheet
Debt/Equity-20.64
Current Ratio0.81
Quick Ratio0.49
Book Value/Sh-3.36 USD
Cash/Share3.72 USD
Dividends
Fwd Div Rate6.92 USD
Trail. Div Rate6.83 USD
Div. Yield2.63%
5Y Avg Yield3.45%
Payout Ratio190.40%
Ex-Div DateOct 15, 2026
Pay DateNov 16, 2026
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)278.86 USD
Upside (mean)+6.0%
Target Range200.00 USD – 328.00 USD
200.00+6.0% to mean328.00
# Analysts28
Ownership
Shares Out.1.77B
Float1.76B
Insiders0.11%
Institutions77.33%
Short Interest
Short Ratio4.4d
Short % Float1.23%
Short % Out.1.10%
Shares Short19.49M
Short (prev mo.)18.30M
Technical
SMA 50257.84 (+2.0%)
SMA 200231.52 (+13.6%)
Beta0.28
S&P 52W Chg14.58%
Avg Vol (30d)3.89M
Avg Vol (10d)3.82M
Technical Indicators
RSI (14)59.0
MACD2.0172
MACD Signal2.3614
MACD Hist.-0.3442
BB Upper271.39 USD
BB Middle261.57 USD
BB Lower251.75 USD
BB Width7.51%
ATR (14)5.333 USD
Vol Ratio (20d)1.02x